Swiss National Bank Adds $13M in Astera Labs, Inc. ($ALAB)
The Swiss National Bank has increased its holdings in Astera Labs by 7.1%, adding 25,800 shares.
Key Points
- Swiss National Bank increased its stake in Astera Labs by 7.1%, adding 25,800 shares to hold a total of 390,164 shares valued at $192.9 million.
- Astera Labs, trading on the NasdaqGS under ALAB, has a market cap of $82.8 billion and a P/E ratio of 330.8, with a 52-week high of $499.48.
- FMR LLC and State Street Corp increased their holdings in Astera Labs, while BlackRock reduced its position by 1.5 million shares.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
The Swiss National Bank has increased its stake in Astera Labs, Inc. (NasdaqGS: ALAB), adding 25,800 shares. This move boosts its holdings by 7.1% to a total of 390,164 shares, valued at approximately $192.9 million. These figures come from the latest Form 13F filing with the SEC, reflecting the bank's position as of the reporting period.
Swiss National Bank vs. the S&P 500
Hypothetical, simulated performance of disclosed positions vs. the S&P 500. Not realized profit and not investment advice. Past performance does not indicate future results. Details.
What Changed in Swiss National Bank's Astera Labs Position
The Swiss National Bank grew its investment in Astera Labs by adding 25,800 shares, marking a 7.1% increase. The bank now holds 390,164 shares in total, with the value of its stake reaching about $192.9 million.
Other Institutional Activity in Astera Labs
FMR LLC increased its holdings in Astera Labs by 194,944 shares, bringing its total to 25,529,885 shares worth about $2.8 billion. In contrast, BlackRock, Inc. trimmed its position by 1,519,089 shares, now holding 11,449,769 shares valued at approximately $1.25 billion. Vanguard Portfolio Management LLC and Vanguard Capital Management LLC both opened new positions, acquiring 7,309,778 and 6,340,732 shares respectively. Atreides Management, LP significantly increased its stake by 1,754,593 shares, ending with 3,365,787 shares valued at $368.9 million. State Street Corp also grew its holdings by 233,797 shares to hold a total of 3,333,606 shares worth $365.4 million.
Astera Labs, Inc. Stock Up 70.8%
Shares of Astera Labs traded near $494.40 on Wednesday. The company, with a market cap of $82.8 billion, has a high P/E ratio of 330.8, reflecting its valuation. Astera Labs has experienced a 52-week range between $85.85 and $499.48. The stock's 50-day moving average is $288.50, while the 200-day moving average is $192.55. The company carries a beta of 3.963, indicating significant volatility. Its financial health is solid with a current ratio of 11.3 and a quick ratio of 10.55, alongside a debt-to-equity ratio of 2.801.
$ALAB stock price
Daily closing prices, year to date. Not investment advice.
Recent Earnings
Astera Labs reported revenue of $1.0 billion, with a robust growth rate of 93.4%. The company's earnings per share (EPS) stood at $1.46, and it maintained a net margin of 26.7%. The return on equity (ROE) was 21.1%, indicating efficient use of shareholder funds. The next earnings report is expected on August 4, 2026.
Earnings drift grade
Outlook vs expectations on the last report — not price action.
-
Forward outlook
10 analysts raised price targets.
-
EPS & revenue
EPS beat estimates by 11.6%. Revenue beat estimates by 3.5%.
-
Profit surprise
EBITDA missed by 34 percent. Operating income missed by 40 percent.
-
Pre-earnings setup
Bar was high, analysts already very bullish.
-
Analyst signal
10 target raises.
-
Earnings quality
Gross margin up 1.4 points. Operating margin up 13.0 points.
Earnings Call Summary
Astera Labs delivered strong Q1 results with revenue of $308 million, up 93 percent year over year, driven by broad growth across signal conditioning and fabric switch products. PCIe Gen 6 products contributed over one third of total revenue. The company shipped initial production volumes of the new Scorpio X 320-lane switch and is expanding optical capabilities through the XScale acquisition, with near-package optics expected to ship in 2027 and chiplet-package optics in 2028.
Guidance Management expects revenue between $355 million and $365 million in the next quarter, up 15 to 18 percent sequentially. They expect non-GAAP earnings per share between $0.68 and $0.70, with gross margin around 73 percent before a one-time customer agreement charge. The Scorpio product line is expected to become their largest business by year end.
Slightly positive report. The quarter was acceptable, but the forward setup is not strong.
Insider Buying and Selling at Astera Labs, Inc.
Recent insider activity at Astera Labs includes planned sales by Bethany Mayer, who sold 686 shares at an average price of $395.04 on June 24, 2026. On June 4, 2026, Jack Lazar sold 10,000 shares at $355.17 under a planned sale. On the same day, Craig Barratt, Michael Hurlston, and Bethany Mayer each bought 837 shares, with the transactions not being pre-planned.
Analysts Set New Price Targets
Analysts have maintained their ratings for Astera Labs, with UBS setting a hold rating and a $400 price target as of June 29, 2026. Stifel reaffirmed its buy rating with a $460 target on June 24, 2026. B of A Securities also kept a hold rating with a $450 target on June 23, 2026. Overall, the consensus among 22 analysts is a buy, with a mean price target of $272.47.
About Astera Labs, Inc.
Astera Labs, Inc., based in San Jose, California, designs and manufactures semiconductor-based connectivity solutions for cloud and AI infrastructure. The company offers products like high-speed, mixed-signal connectivity solutions and the COSMOS software suite for managing large-scale cloud resources. Founded in 2017, Astera Labs serves a global market, including hyperscalers and system original equipment manufacturers.
Bottom Line
The Swiss National Bank's increased stake in Astera Labs highlights continued institutional interest in the semiconductor firm. As a leader in connectivity solutions, Astera Labs remains a key player in the technology sector. Investors keep a close watch on such 13F filings for insights into institutional sentiment, though it's important to remember these filings are backward-looking and may not reflect current positions.
Get Astera Labs, Inc. alerts
New 13F filings, insider trades, and analyst moves on $ALAB, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.